Reliance Life Sciences Private Limited: Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for
Read the official notice at FDA (drug) →
Get alerts for Reliance Life Sciences Private
The text below is copied from the official FDA (drug) record. If anything differs, the official notice is correct.
- Company / brand
- Reliance Life Sciences Private Limited
- Product
- Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Intravenous Use, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0857-01
- Reason / hazard
- Lack of Sterility Assurance
- Classification
- Class II
- Status
- Ongoing
- Distribution / sold at
- Nationwide in the USA
- Recall initiated
- 2026-06-24
- Code info
- Lot, expiry: RAZM0425A Jun 30, 2027; RAZM0525A Jun 30, 2027; RAZM0725A Jun 30, 2027; RAZM0825A Jun 30, 2027; RAZM0925A Jul 31, 2027; RAZM1125A Jul 31, 2027; RAZM1225A Jul 31, 2027; RAZM1425A Jul 31, 2027; RAZM1525A Jul 31, 2027; RAZM1625A Aug 31, 2027; RAZM1725A Aug 31, 2027; RAZM2025A Sep 30, 2027
- Product quantity
- 8,001 vials
- Voluntary mandated
- Voluntary: Firm initiated
- City
- Navi Mumbai
- State
- N/A
- Country
- India
- Event id
- 99312
Free daily digest + "My products" watchlist